Toxicity and response to thiopurines in patients with inflammatory bowel disease.
about
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityDrugs for discoid lupus erythematosus.More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.Selection and use of immunosuppressive therapies after liver transplantation: current German practice.Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy.Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
P2860
Q28115755-42827021-5752-477E-8447-069DB9600706Q30234556-59B4DEFC-FC74-42B1-9650-916C149BCAC1Q38712266-6F436955-969E-474A-A69B-0D57ADF43630Q38726102-273C15A6-79BD-4D9C-81EC-AA794F368713Q40044141-ED363CEC-E3CC-4808-81BD-622CBB304D86Q51735726-DAF267F8-ACC9-42A8-B020-F5B72CB4CC02Q55114620-07949A02-8301-4367-8D04-A11DEBCED9F3
P2860
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
@en
type
label
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
@en
prefLabel
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
@en
P2860
P1476
Toxicity and response to thiopurines in patients with inflammatory bowel disease.
@en
P2093
Peter M Irving
Rimma Goldberg
P2860
P304
P356
10.1586/17474124.2015.1039987
P577
2015-04-27T00:00:00Z